Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. QIAGEN N.V.
  6. News
  7. Summary
    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

06/08/2021 | 04:05pm EDT

DGAP Voting Rights Announcement: QIAGEN N.V.
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

08.06.2021 / 22:04
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


The AFM (the Netherlands Authority For the Financial Markets has informed us on June 5, 2021 that a notification related to our institution has been released by the AFM.

The following notification has been disclosed in the relevant register on the AFM website:

Date of transaction: 01 jun 2021
Person obliged to notify: Goldman Sachs Group Inc., The
Issuing institution: Qiagen N.V.
Registration Chamber of Commerce: 12036979
Place of residence: VENLO

Distribution in numbers

Type of share Number of shares Number of voting rights Capital interest Voting rights Manner of disposal Settlement
Ordinary share 32,00 32,00 Real Real Indirectly - Folio Investments Inc. Physical Delivery
Warrant 61.437,00 61.437,00 Potential Potential Indirectly - Goldman Sachs International In cash
Ordinary share 5.775,00 5.774,94 Real Real Indirectly - Goldman Sachs Bank Europe SE Physical Delivery
Convertible bond 510.282,00 510.282,00 Potential Potential Indirectly - Goldman Sachs International Physical Delivery
Contract for difference 279,00 279,00 Potential Potential Indirectly - Goldman Sachs & Co. LLC In cash
Contract for difference 593.467,00 593.467,00 Potential Potential Indirectly - Goldman Sachs International In cash
Swap 79.272,00 79.272,00 Potential Potential Indirectly - Goldman, Sachs & Co. Wertpapier GmbH In cash
Ordinary share 285.585,00 285.582,14 Real Real Indirectly - Goldman Sachs International Physical Delivery
Swap 2.044,00 2.044,00 Potential Potential Indirectly - Goldman Sachs & Co. LLC In cash
Ordinary share 2.543,00 2.543,00 Real Real Indirectly - United Capital Financial Advisers, LLC Physical Delivery
Swap 14.428,00 14.428,00 Potential Potential Indirectly - Goldman Sachs International In cash
Warrant 2.029,00 2.029,00 Potential Potential Indirectly - Goldman, Sachs & Co. Wertpapier GmbH In cash
Option 3.863.782,00 3.863.782,00 Potential Potential Indirectly - Goldman Sachs & Co. LLC Physical Delivery
Ordinary share 295.086,00 295.083,05 Potential Potential Indirectly - Goldman Sachs & Co. LLC Physical Delivery
Ordinary share 609.198,00 609.191,91 Potential Potential Indirectly - Goldman Sachs International Physical Delivery
 

 

Distribution in percentages

Type Total holding Directly real Directly potential Indirectly real Indirectly potential
Capital interest 2,74% 0,00% 0,00% 0,13% 2,61%
Voting rights 2,74% 0,00% 0,00% 0,13% 2,61%
 

QIAGEN N.V. is not responsible for the accuracy and correctness of the notification above. The content has been taken from the relevant register of the AFM:
https://www.afm.nl/en/professionals/registers/meldingenregisters/substantiele-deelnemingen/details?id=113413



08.06.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: QIAGEN N.V.
Hulsterweg 82
5912 PL Venlo
Netherlands
Internet: www.qiagen.com

 
End of News DGAP News Service

1204937  08.06.2021 

fncls.ssp?fn=show_t_gif&application_id=1204937&application_name=news&site_id=zonebourse_sftp

ę EQS 2021
All news about QIAGEN N.V.
08/02DGAP-CMS : QIAGEN N.V.: Release of a capital market information
DJ
08/02QIAGEN N.V. : Release of a capital market information
EQ
08/02QIAGEN N : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS (Form 6-K)
PU
08/02QIAGEN N : Chief Financial Officer (Form 6-K)
PU
07/30QIAGEN N : Thinking about trading options or stock in Atlassian, Crispr Therapeu..
PR
07/30QIAGEN N : QIAGEN reports full results for Q2 and H1 2021
PU
07/29QIAGEN : Q2 Earnings Snapshot
AQ
07/29QIAGEN N : Earnings, Sales Jump in Q2; Reiterates FY21 Revenue Growth, EPS Guida..
MT
07/29QIAGEN N : Reports Full Results for Q2 and H1 2021
BU
07/29QIAGEN N.V. Provides Earnings Guidance for Full Year 2021
CI
More news
Financials (USD)
Sales 2021 2 136 M - -
Net income 2021 446 M - -
Net Debt 2021 727 M - -
P/E ratio 2021 27,3x
Yield 2021 -
Capitalization 12 037 M 12 037 M -
EV / Sales 2021 5,97x
EV / Sales 2022 6,19x
Nbr of Employees 5 900
Free-Float 98,2%
Chart QIAGEN N.V.
Duration : Period :
QIAGEN N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QIAGEN N.V.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 52,72 $
Average target price 53,13 $
Spread / Average Target 0,77%
EPS Revisions
Managers and Directors
Thierry Bernard Chief Executive Officer & Managing Director
Roland Sackers Chief Financial Officer & Managing Director
Lawrence A. Rosen Chairman-Supervisory Board
Barthold Piening Senior Vice President & Head-Global Operations
Metin Colpan Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
QIAGEN N.V.-0.25%12 037
MODERNA, INC.301.12%168 260
LONZA GROUP AG26.76%59 023
IQVIA HOLDINGS INC.39.45%47 876
CELLTRION, INC.-24.93%32 166
SEAGEN INC.-6.81%29 694